In the links below please find the slides and a letter from Dr. Januzzi summarizing his concluding thoughts from our Think Tank held in Washington DC on June 6th, 2017.
About the Think Tank on Regulatory Aspects of Natriuretic Peptide Clinical Trial:
Baim Institute for Clinical Research was proud to sponsor a face-to-face think tank that brought together thought leaders from noted institutions/organizations to discuss important topics relevant to the regulatory approval of important biomarker assays in heart failure. The event was held at the ACC Heart House on June 6th, 2017, with participants from industry, academia and regulatory bodies.
The event was officially endorsed by the American Association for Clinical Chemistry. Dedicated to achieving better health through laboratory medicine, AACC brings together more than 50,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit www.aacc.org.